Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)
Dr. Joseph Kim discusses with Equities.com discuses the potential of synthetic vaccines and immune therapies for cancers and infectious diseases.
This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
- Claude Vezeau, CEO of Calevia sits to...
- Published on 19 September 2013
- Views (814)
- Equities.com sits down with Ellis...
- Published on 08 November 2011
- Views (498)
- Equities.com sits down to talk with...
- Published on 06 December 2011
- Views (511)